Table 1 Baseline demographic and pre-operative characteristics stratified by post-operative CSA-AKI.
Characteristic | No AKI (n = 92) | AKI (n = 65) | p-value |
|---|---|---|---|
Age (years) (mean[± SD]) | 64.7 ± 15.8 | 67.5 ± 13 | 0.33 |
Male Sex (%) | 64 (69.6) | 46 (70.8) | 0.87 |
BMI (kg/m2) (mean[± SD]) | 26.3 ± 4.1 | 31.5 ± 7.1 | < 0.0001 |
CAD (%) | 42 (45.7) | 38 (58.5) | 0.11 |
Angina (%) | 8 (8.7) | 5 (7.7) | 0.83 |
Previous MI | 35 (38) | 31 (47.7) | 0.23 |
Previous Revascularization (%) | 9 (9.8) | 4 (6.2) | 0.42 |
Valve disease (%) | 52 (56.5) | 27 (41.5) | 0.06 |
HTN (%) | 51 (55.4) | 44 (67.7) | 0.12 |
DM - Insulin-Dependent (%) | 8 (8.7) | 14 (21.5) | 0.02 |
DM - Non Insulin Dependent (%) | 23 (25) | 24 (36.9) | 0.12 |
Dyslipidemia (%) | 57 (62) | 48 (73) | 0.12 |
PVD (%) | 9 (9.8) | 11 (16.9) | 0.19 |
CVD (%) | 9 (9.8) | 5 (7.7) | 0.65 |
Creatinine (μmol/L) (mean[± SD]) | 102.1 ± 29.3 | 100.3 ± 24.1 | 0.98 |
Chronic Kidney Disease (%) | 12 (13) | 9 (13.8) | 0.88 |
Pre-op SBP (mm Hg) (mean [± SD]) | 123.6 ± 21.1 | 129.5 ± 20.9 | 0.07 |
Pre-op DBP (mm Hg) (mean [± SD]) | 66.5 ± 13.3 | 67.4 ± 13.3 | 0.66 |
Pre-op MAP (mm Hg) (mean [± SD]) | 85.5 ± 13.2 | 88.1 ± 13.2 | 0.22 |
EF (%)(mean [± SD]) | 48.4 ± 13.2 | 47.5 ± 13.6 | 0.55 |
ASA (%) | 76 (82.6) | 54 (83.1) | 0.90 |
Clopidogrel (%) | 12 (13.0) | 9 (13.8) | 0.88 |
Beta-Blocker (%) | 62 (67.5) | 45 (69.2) | 0.81 |
CCB (%) | 17 (18.5) | 11 (16.9) | 0.08 |
ACE inhibitor (%) | 56 (60.9) | 31 (47.7) | 0.10 |
ARB (%) | 6 (6.5) | 3 (4.6) | 0.62 |
Statin (%) | 60 (65.2) | 46 (70.3) | 0.46 |
Loop Diuretic (%) | 34 (37) | 28 (43.1) | 0.44 |
Thiazide (%) | 35 (38) | 31 (47.7) | 0.23 |
Spironolactone (%) | 2 (2.2) | 4 (6.2) | 0.23 |